AMIVAS is a US, Australian and European joint-venture pharmaceutical company that develops, manufactures and distributes Artesunate for the emergency treatment of severe malaria. With offices in the United States, Australia and Ireland, it manufactures in North America and works with regional partners to supply hospitals and patients across multiple markets. Its first commercial product received U.S. FDA approval on May 26, 2020, after quinidine gluconate was discontinued in 2019.
U.S. Food and Drug Administration (FDA) approval for Artesunate
Registration
Medicines and Healthcare products Regulatory Agency (MHRA) authorization for Artesunate
Registration
European Medicines Agency (EMA) registration for Artesunate
Registration
SERB PharmaceuticalsSERB Pharmaceuticals develops, manufactures, and supplies specialist medicines for rare diseases and medical emergencies, with a particular strength in antidotes and other critical-care treatments. Beginning in the 1950s as Société d’Études et de Recherches Biologiques, the company now supplies more than 70 medicines through direct operations and distribution partners in over 100 countries. Its fully integrated platform includes a commercial-scale polyclonal antibody manufacturing capability and four manufacturing facilities across three continents.325412CONSHOHOCKEN, PA
American Regent, IncFounded in 1967 as American Quinine, American Regent is a U.S.-based pharmaceutical manufacturer producing branded and generic sterile injectable medicines for human and animal health. The company is particularly known for its long-standing IV iron business, while its animal health operation has served horses and dogs for more than 40 years. American Regent is part of the Daiichi Sankyo Group and has expanded and modernized its U.S. manufacturing capacity to help maintain reliable supplies of essential medicines.NEW ALBANY, OH
On Demand PharmaceuticalsCo-founded by Dr. Geoffrey Ling after experiences in Afghanistan and Iraq, Rockville-based On Demand Pharmaceuticals develops distributed systems for producing medicines at or near the point of care. Its Pharmacy on Demand™ platform supports agile 503A and 503B production, including sterile injectables, to help hospitals respond to drug shortages and reduce dependence on fragile global supply chains. A 2024 pilot with North Mississippi Health Services produced approximately 12,000 prefilled syringes without a quality failure or adverse patient event.ROCKVILLE, MD
Emergent BioSolutionsEmergent BioSolutions is a public health company that develops and manufactures protective medicines and medical countermeasures for opioid overdose emergencies and biological threats. Founded in 1998, it began by partnering with the U.S. government to supply an anthrax vaccine and now operates manufacturing facilities across the United States and Canada, alongside research and development and commercial product operations.325412PLYMOUTH MEETING, PA